u/UnfairRazzmatazz987 · 2h ago1 prior · 100% at 3mo
$CMPS Next Stop $30
After-hours price action suggests a breakout above $17 resistance could drive Compass Pathways to $30 per share.
At post $14.04Now $14.040.0% since postedas of Sep 8, 4:30 PM ET
u/UnfairRazzmatazz987
2 theses · first seen May 25, 2026
| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | 1 | 1 | 0 | 0% | -3.1% | -3.1% |
| 3d | 1 | 1 | 0 | 0% | -5.4% | -5.4% |
| 1w | 1 | 1 | 0 | 0% | -0.8% | -0.8% |
| 1m | 1 | 1 | 1 | 100% | +10.2% | +10.2% |
| 3m | 1 | 1 | 1 | 100% | +22.1% | +22.1% |
| 6m | 0 | 0 | 0 | — | — | — |
| 1y | 0 | 0 | 0 | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
Thesis history
u/UnfairRazzmatazz987 · 118d ago1 prior · 100% at 3mo
CMPS to $40 Is Starting to Look Very Real
CMPS is positioned to become a leader in psychedelic medicine with COMP360 in Phase 3 for treatment-resistant depression and FDA breakthrough therapy designation. Approval would unlock a massive new treatment category, making $40 a realistic target that still undervalues the company's market opportunity.
At post $10.96Now $14.04+28.1% since postedas of Sep 8, 4:30 PM ET
1d-3.1%
3d-5.4%
1w-0.8%
1m+10.2%
3m+22.1%
6m—
1y—
End of results.